Inglés

The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 formularios  
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000372.v2.p1
Descripción

pht000372.v2.p1

DUMMY ID NUMBER
Descripción

ID2

Tipo de datos

string

ASSESSMENT PERIOD (ALL PARTICIPANTS)
Descripción

VIS

Tipo de datos

string

DAILY DIETARY ESTIMATES OF CALORIES (ALL PARTICIPANTS)
Descripción

DT_KCAL

Tipo de datos

float

TOTAL FAT (G) (ALL PARTICIPANTS)
Descripción

DT_FAT

Tipo de datos

float

CARBOHYDRATE (G) (ALL PARTICIPANTS)
Descripción

DT_CARB

Tipo de datos

float

CALCIUM (MG) (ALL PARTICIPANTS)
Descripción

DT_CALC

Tipo de datos

float

PHOSPHORUS (MG) (ALL PARTICIPANTS)
Descripción

DT_PHOS

Tipo de datos

float

IRON (MG) (ALL PARTICIPANTS)
Descripción

DT_FE

Tipo de datos

float

SODIUM (MG) (ALL PARTICIPANTS)
Descripción

DT_NA

Tipo de datos

float

POTASSIUM (MG) (ALL PARTICIPANTS)
Descripción

DT_POTA

Tipo de datos

float

VITAMIN A IU (IU) (ALL PARTICIPANTS)
Descripción

DT_A_IU

Tipo de datos

float

VITAMIN A RE (MCG) (ALL PARTICIPANTS)
Descripción

DT_A_RE

Tipo de datos

float

THIAMIN (MG) (ALL PARTICIPANTS)
Descripción

DT_B1

Tipo de datos

float

RIBOFLAVIN (MG) (ALL PARTICIPANTS)
Descripción

DT_RIBO

Tipo de datos

float

NIACIN (MG) (ALL PARTICIPANTS)
Descripción

DT_NIAC

Tipo de datos

float

VITAMIN C (MG) (ALL PARTICIPANTS)
Descripción

DT_VITC

Tipo de datos

float

TOTAL SATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
Descripción

DT_SFAT

Tipo de datos

float

OLEIC ACID (MUFA 18:1) (G) (ALL PARTICIPANTS)
Descripción

DT_OLEC

Tipo de datos

float

CHOLESTEROL (MG) (ALL PARTICIPANTS)
Descripción

DT_CHOL

Tipo de datos

float

FOLATE (MCG) (ALL PARTICIPANTS)
Descripción

DT_FOL

Tipo de datos

float

TOTAL VITAMIN E ACTIVITY (ALL PARTICIPANTS)
Descripción

DT_VITE

Tipo de datos

float

ZINC (MG) (ALL PARTICIPANTS)
Descripción

DT_ZINC

Tipo de datos

float

VITAMIN B6 (MG) (ALL PARTICIPANTS)
Descripción

DT_B6

Tipo de datos

float

MAGNESIUM (MG) (ALL PARTICIPANTS)
Descripción

DT_MG

Tipo de datos

float

ALPHA-CAROTENE (MCG) (ALL PARTICIPANTS)
Descripción

DT_ACAR

Tipo de datos

float

BETA-CAROTENE (MCG) (ALL PARTICIPANTS)
Descripción

DT_BCAR

Tipo de datos

float

BETA-CRYPTOXANTHIN (MCG) (ALL PARTICIPANTS)
Descripción

DT_CRYP

Tipo de datos

float

LUTEIN+ZEAXANTHIN (MCG) (ALL PARTICIPANTS)
Descripción

DT_LUT

Tipo de datos

float

LYCOPENE (MCG) (ALL PARTICIPANTS)
Descripción

DT_LYC

Tipo de datos

float

RETINOL (MCG) (ALL PARTICIPANTS)
Descripción

DT_RET

Tipo de datos

float

BETA-CAROTENE EQUIVALENTS (MCG) (ALL PARTICIPANTS)
Descripción

DT_PROA

Tipo de datos

float

VEGETABLE PROTEIN (G) (ALL PARTICIPANTS)
Descripción

DT_VPROT

Tipo de datos

float

LINOLEIC ACID (PUFA 18:2) (G) (ALL PARTICIPANTS)
Descripción

DT_PUFA182

Tipo de datos

float

SOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
Descripción

DT_SFIB

Tipo de datos

float

ANIMAL PROTEIN (G) (ALL PARTICIPANTS)
Descripción

DT_APROT

Tipo de datos

float

SELENIUM (MCG) (ALL PARTICIPANTS)
Descripción

DT_SEL

Tipo de datos

float

TOTAL POLYUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
Descripción

DT_PUFA

Tipo de datos

float

TOTAL MONOUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
Descripción

DT_MUFA

Tipo de datos

float

ALCOHOL (G) (ALL PARTICIPANTS)
Descripción

DT_ALC

Tipo de datos

float

GALACTOSE (G) (ALL PARTICIPANTS)
Descripción

DT_GAL

Tipo de datos

float

LACTOSE (G) (ALL PARTICIPANTS)
Descripción

DT_LACT

Tipo de datos

float

INSOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
Descripción

DT_IFIB

Tipo de datos

float

VITAMIN D (MCG) (ALL PARTICIPANTS)
Descripción

DT_VITD

Tipo de datos

float

VITAMIN B12 (MCG) (ALL PARTICIPANTS)
Descripción

DT_B12

Tipo de datos

float

COPPER (MG) (ALL PARTICIPANTS)
Descripción

DT_CU

Tipo de datos

float

EICOSAPENTAENOIC ACID (G) (ALL PARTICIPANTS)
Descripción

EPA

Tipo de datos

float

DOCOSAHEXAENOIC ACID (G) (ALL PARTICIPANTS)
Descripción

DHA

Tipo de datos

float

TRYPTOPHAN (G) (ALL PARTICIPANTS)
Descripción

DT_TRYP

Tipo de datos

float

METHIONINE (G) (ALL PARTICIPANTS)
Descripción

DT_MET

Tipo de datos

float

GLUTAMIN ACID (G) (ALL PARTICIPANTS)
Descripción

DT_GLUT

Tipo de datos

float

LINOLENIC ACID (G) (ALL PARTICIPANTS)
Descripción

DT_PUFA183

Tipo de datos

float

ARACHIDONIC ACID (G) (ALL PARTICIPANTS)
Descripción

DT_PUFA204

Tipo de datos

float

YEARS FROM RANDOMIZATION TO DATE OF FOLLOW-UP ASSESSMENT (If available) (ALL PARTICIPANTS)
Descripción

FFQTIME

Tipo de datos

float

DIETARY GLYCEMIC LOAD (ALL PARTICIPANTS)
Descripción

DGL

Tipo de datos

float

DIETARY GLYCEMIC INDEX (ALL PARTICIPANTS)
Descripción

DGI

Tipo de datos

float

TOTAL AVAILABLE DIETARY CARBOHYDRATES (G) (ALL PARTICIPANTS)
Descripción

TACHO

Tipo de datos

float

Volver a la parte superior de la página

Similar models

The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 formularios
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
pht000372.v2.p1
ID2
Item
DUMMY ID NUMBER
string
VIS
Item
ASSESSMENT PERIOD (ALL PARTICIPANTS)
string
DT_KCAL
Item
DAILY DIETARY ESTIMATES OF CALORIES (ALL PARTICIPANTS)
float
DT_FAT
Item
TOTAL FAT (G) (ALL PARTICIPANTS)
float
DT_CARB
Item
CARBOHYDRATE (G) (ALL PARTICIPANTS)
float
DT_CALC
Item
CALCIUM (MG) (ALL PARTICIPANTS)
float
DT_PHOS
Item
PHOSPHORUS (MG) (ALL PARTICIPANTS)
float
DT_FE
Item
IRON (MG) (ALL PARTICIPANTS)
float
DT_NA
Item
SODIUM (MG) (ALL PARTICIPANTS)
float
DT_POTA
Item
POTASSIUM (MG) (ALL PARTICIPANTS)
float
DT_A_IU
Item
VITAMIN A IU (IU) (ALL PARTICIPANTS)
float
DT_A_RE
Item
VITAMIN A RE (MCG) (ALL PARTICIPANTS)
float
DT_B1
Item
THIAMIN (MG) (ALL PARTICIPANTS)
float
DT_RIBO
Item
RIBOFLAVIN (MG) (ALL PARTICIPANTS)
float
DT_NIAC
Item
NIACIN (MG) (ALL PARTICIPANTS)
float
DT_VITC
Item
VITAMIN C (MG) (ALL PARTICIPANTS)
float
DT_SFAT
Item
TOTAL SATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
float
DT_OLEC
Item
OLEIC ACID (MUFA 18:1) (G) (ALL PARTICIPANTS)
float
DT_CHOL
Item
CHOLESTEROL (MG) (ALL PARTICIPANTS)
float
DT_FOL
Item
FOLATE (MCG) (ALL PARTICIPANTS)
float
DT_VITE
Item
TOTAL VITAMIN E ACTIVITY (ALL PARTICIPANTS)
float
DT_ZINC
Item
ZINC (MG) (ALL PARTICIPANTS)
float
DT_B6
Item
VITAMIN B6 (MG) (ALL PARTICIPANTS)
float
DT_MG
Item
MAGNESIUM (MG) (ALL PARTICIPANTS)
float
DT_ACAR
Item
ALPHA-CAROTENE (MCG) (ALL PARTICIPANTS)
float
DT_BCAR
Item
BETA-CAROTENE (MCG) (ALL PARTICIPANTS)
float
DT_CRYP
Item
BETA-CRYPTOXANTHIN (MCG) (ALL PARTICIPANTS)
float
DT_LUT
Item
LUTEIN+ZEAXANTHIN (MCG) (ALL PARTICIPANTS)
float
DT_LYC
Item
LYCOPENE (MCG) (ALL PARTICIPANTS)
float
DT_RET
Item
RETINOL (MCG) (ALL PARTICIPANTS)
float
DT_PROA
Item
BETA-CAROTENE EQUIVALENTS (MCG) (ALL PARTICIPANTS)
float
DT_VPROT
Item
VEGETABLE PROTEIN (G) (ALL PARTICIPANTS)
float
DT_PUFA182
Item
LINOLEIC ACID (PUFA 18:2) (G) (ALL PARTICIPANTS)
float
DT_SFIB
Item
SOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
float
DT_APROT
Item
ANIMAL PROTEIN (G) (ALL PARTICIPANTS)
float
DT_SEL
Item
SELENIUM (MCG) (ALL PARTICIPANTS)
float
DT_PUFA
Item
TOTAL POLYUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
float
DT_MUFA
Item
TOTAL MONOUNSATURATED FATTY ACIDS (G) (ALL PARTICIPANTS)
float
DT_ALC
Item
ALCOHOL (G) (ALL PARTICIPANTS)
float
DT_GAL
Item
GALACTOSE (G) (ALL PARTICIPANTS)
float
DT_LACT
Item
LACTOSE (G) (ALL PARTICIPANTS)
float
DT_IFIB
Item
INSOLUBLE DIETARY FIBER (G) (ALL PARTICIPANTS)
float
DT_VITD
Item
VITAMIN D (MCG) (ALL PARTICIPANTS)
float
DT_B12
Item
VITAMIN B12 (MCG) (ALL PARTICIPANTS)
float
DT_CU
Item
COPPER (MG) (ALL PARTICIPANTS)
float
EPA
Item
EICOSAPENTAENOIC ACID (G) (ALL PARTICIPANTS)
float
DHA
Item
DOCOSAHEXAENOIC ACID (G) (ALL PARTICIPANTS)
float
DT_TRYP
Item
TRYPTOPHAN (G) (ALL PARTICIPANTS)
float
DT_MET
Item
METHIONINE (G) (ALL PARTICIPANTS)
float
DT_GLUT
Item
GLUTAMIN ACID (G) (ALL PARTICIPANTS)
float
DT_PUFA183
Item
LINOLENIC ACID (G) (ALL PARTICIPANTS)
float
DT_PUFA204
Item
ARACHIDONIC ACID (G) (ALL PARTICIPANTS)
float
FFQTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF FOLLOW-UP ASSESSMENT (If available) (ALL PARTICIPANTS)
float
DGL
Item
DIETARY GLYCEMIC LOAD (ALL PARTICIPANTS)
float
DGI
Item
DIETARY GLYCEMIC INDEX (ALL PARTICIPANTS)
float
TACHO
Item
TOTAL AVAILABLE DIETARY CARBOHYDRATES (G) (ALL PARTICIPANTS)
float
Volver a la parte superior de la página